BRIEF-Multisensor Ai Holdings Inc Sees IPO Of 4.7 Million Shares Of Common Stock-March 2024-www.financetom.com

BRIEF-Multisensor Ai Holdings Inc Sees IPO Of 4.7 Million Shares Of Common Stock

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Multisensor Ai Holdings Inc Sees IPO Of 4.7 Million Shares Of Common Stock

Jun 24, 2024 3:50 AM

June 24 (Reuters) - Multisensor AI Holdings Inc ( MSAI )

* MULTISENSOR AI HOLDINGS INC ( MSAI ): SEES IPO OF 4.7 MILLION

SHARES OF

COMMON STOCK- SEC FILING

Source text for Eikon:

Further company coverage:

Previous page： Update: Market Chatter: Alphabet's Waymo Robotaxis Under Probe Over Safety Around School Buses Next page： Market Chatter: Apple Faces China Antitrust Complaint Over App Store Practices

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Update: Market Chatter: Alphabet's Waymo Robotaxis Under Probe Over Safety Around School Buses

Oct 20, 2025

07:38 AM EDT, 10/20/2025 (MT Newswires) -- (Updates with company comments in the fourth paragraph.) Alphabet's (GOOG, GOOGL) Waymo is under a preliminary investigation by the US National Highway Traffic Safety Administration covering some 2,000 self-driving vehicles following reports that the firm's robotaxis may have been unable to follow traffic safety rules around stopped school buses, Reuters reported Monday, citing...

Market Chatter: Apple Faces China Antitrust Complaint Over App Store Practices

Oct 20, 2025

07:40 AM EDT, 10/20/2025 (MT Newswires) -- Apple ( AAPL ) is facing a complaint filed with China's market regulator alleging abuse of its market position by restricting app distribution and payments to its own iOS platform on iPhones and iPads, Reuters reported Monday. The report cited a lawyer as saying that a filing to China's State Administration for Market...

Biopharma firm CorMedix's preliminary Q3 revenue beats estimates, raises FY guidance

Oct 20, 2025

Overview * CorMedix's preliminary Q3 2025 revenue beats expectations, driven by strong DefenCath utilization * Company raises FY 2025 revenue guidance to at least $375 mln * CorMedix ( CRMD ) expects $30 mln operating synergy before year-end 2025 Outlook * CorMedix ( CRMD ) raises FY 2025 pro forma net revenue guidance to at least $375 mln * Company...

Glaukos Says Drug Treating Keratoconus Receives FDA Approval

Oct 20, 2025

07:40 AM EDT, 10/20/2025 (MT Newswires) -- Glaukos ( GKOS ) said Monday its new drug application for Epioxa, a topical drug therapy for the eye disorder keratoconus, has been approved by the US Food and Drug Administration. The approval of the drug is based on results from two phase 3 pivotal trials of over 400 patients that achieved their...